Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Most Read

  1. Pfizer’s blockbuster drug Lyrica comes off-patent in 2018
  2. Unlocking cell-free protein synthesis: biotech’s next big ticket?
  3. FDA files legal complaint against BioDefense
  4. ASCO 2018: combinations vs single agent in melanoma immunotherapy
  5. ASCO 2018: after Revlimid results, is superior safety worth the cost?

Latest Content

ASCO 2018: combinations vs single agent in melanoma immunotherapy

One of the very first sessions at this year’s ASCO meeting was an education session that neatly summarised the current status of immunotherapy combination research in melanoma. The indication in which the anti-PD-1 checkpoint inhibitor revolution began back in 2014, melanoma continues to serve as a testing ground for novel strategies.

Welcome to DJA-Pharma

DJA-Pharma is a turnkey pharmaceutical solutions provider that proposes suitable equipment and services to match client's needs for growth.

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Go Top